Clik here to view.
Objective Acuity’s Trials Confirm Visual Acuity Testing Breakthrough
AUCKLAND, New Zealand Objective Acuity has reached a significant milestone in its development of the world’s first, objective, visual acuity test. It has successfully concluded proof of concept...
View ArticleClik here to view.
PeptiDream Announces Drug Discovery and Development Agreement with Santen...
KAWASAKI, Japan PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a broad-based multi-target discovery and...
View ArticleClik here to view.
Visioneering Technologies Selects Corneal Lens Corporation NZ and Contact...
ATLANTA Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, today announced that it has signed an...
View ArticleClik here to view.
Visioneering Technologies, Inc. Enters European Market
ATLANTA Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, today announced that Medilens Nordic...
View ArticleClik here to view.
PPG, Essilor Celebrate Launch of COLORFUL COMMUNITIES Project at Susrut Eye...
KOLKATA, India PPG (NYSE:PPG) and Essilor International today announced the launch of a COLORFUL COMMUNITIES™ project in Kolkata, India, that will help revitalize the Susrut Eye Foundation and...
View ArticleClik here to view.
Prospective Study for NaturalVue Multifocal Demonstrates Decreased Refractive...
ATLANTA Thomas Aller, OD, FBCLA, an internationally recognized expert in nearsightedness in children, has presented updated findings from a prospective clinical trial of NaturalVue® (etafilcon A) 1...
View ArticleClik here to view.
Visioneering Technologies Inc. Appoints Dr. Peg Achenbach as Vice President,...
ATLANTA To ensure that Eye Care Professionals (ECPs) fully connect with its technology and growing product portfolio, Visioneering Technologies Inc. (VTI), a global company dedicated to improving...
View ArticleClik here to view.
Visioneering Technologies Inc. Appoints Brian Lane as Chief Financial Officer
ATLANTA Vision care company and manufacturer of the NaturalVue® Multifocal contact lens, Visioneering Technologies (ASX:VTI), is pleased to announce that it has named Brian D. Lane, CPA, as its...
View ArticleClik here to view.
STAAR Surgical Expects Fourth Quarter ICL Sales to Rise 42%; China Units...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary...
View ArticleClik here to view.
ファインデックス、視線分析型視野計GAPの薬事申請が受理
東京 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京 代表取締役：相原輝夫、以下ファインデックス）は、「視線分析型視野計ゲイズアナライジングペリメーターGAP（以下、GAP）」を開発し、2019年1月16日に医薬品医療機器総合機構（通称PMDA）への届け出が受理されました。...
View ArticleClik here to view.
ファインデックス、健診施設向けに視線分析型視野計GAP-screenerを発売開始
東京 （ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京 代表取締役：相原輝夫、以下ファインデックス）は、「視線分析型視野計ゲイズアナライジングペリメーター GAP-screener（以下、GAP-screener）」を、2019年2月25日より健診施設や人間ドックを行う医療機関を中心に販売を開始します。...
View ArticleClik here to view.
香港国际眼镜展于11月举行
香港 第27届香港国际眼镜展将于2019年11月6至8日假香港会议展览中心隆重举行。今届展览将汇聚来自20多个国家及地区、约800家展商。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20191007005885/zh-CN/ (Photo: Business Wire) 优质商贸平台 开拓国际视野...
View ArticleClik here to view.
Hong Kong International Optical Fair Opens in November
HONG KONG The 27th edition of the HKTDC Hong Kong International Optical Fair will be held from 6-8 Nov 2019 at the Hong Kong Convention and Exhibition Centre. This year, the fair will welcome around...
View ArticleClik here to view.
Tej Kohli Foundation advocates a scalable, accessible and affordable...
LONDON On World Sight Day, the Tej Kohli Foundation says that a focus on new technologies is needed to accelerate the global mission to end curable corneal blindness worldwide. The Foundation is...
View ArticleClik here to view.
香港国際オプティカルフェアを11月に開催
香港 （ビジネスワイヤ） — 第27回HKTDC香港国際オプティカルフェアが、2019年11月6～8日に香港会議展覧中心で開催されます。今年の見本市には、約20の国・地域から約800社が出展します。...
View ArticleClik here to view.
Harbour BioMed Announces Completion of Phase 2 Study in China of HBM9036 In...
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI Harbour BioMed (HBM) today announced completion of a Phase 2 study in China of HBM9036 (tanfanercept), a new, investigational TNF...
View ArticleClik here to view.
Tej Kohli基金会倡导一种可扩展、易获取且平价的技术解决方案来终结全球角膜失明
伦敦 (美国商业资讯)–在世界视力日，Tej Kohli基金会表示，必须专注于新技术，才能加快在全世界终结可治愈角膜失明的全球使命。基金会目前正在资助临床试验和一种“液态生物合成”解决方案的开发，该解决方案有望提供易获取、可扩展且平价的角膜失明解决方案，这种解决方案对于全世界1200万角膜失明患者中的许多人是至关重要的。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
CORRECTING and REPLACING Harbour BioMed Announces Completion of Phase 2 Study...
CAMBRIDGE, Mass. & ROTTERDAM, The Netherlands & SHANGHAI Sixth paragraph, second sentence should read: “DED is more prevalent in Asia; over 100 million people in China are estimated to be...
View ArticleClik here to view.
Clik here to view.
EMA and FDA Accept Marketing Applications for Chugai’s Satralizumab in...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application for satralizumab (development code:...
View Article